Cerner Corporation (CERN)
| Market Cap | 23.50B |
| Revenue (ttm) | 5.48B |
| Net Income (ttm) | 805.18M |
| Shares Out | 304.73M |
| EPS (ttm) | 2.61 |
| PE Ratio | 29.97 |
| Forward PE | 24.27 |
| Dividend | $0.80 |
| Dividend Yield | 1.02% |
| Trading Day | July 26 |
| Last Price | $78.29 |
| Previous Close | $78.41 |
| Change ($) | -0.12 |
| Change (%) | -0.15% |
| Day's Open | 78.31 |
| Day's Range | 77.67 - 78.83 |
| Day's Volume | 2,099,306 |
| 52-Week Range | 66.17 - 83.71 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cerner's (CERN) second-quarter results are likely to reflect gains from strategic deals.
Cerner (CERN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cerner (CERN) expands its partnership with Baystate Health by launching a digital health platform to boost consumer-focused care.
KANSAS CITY, Mo., July 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its second quarter 2021 earnings results before the market opens Friday, July 30. Fo...
Expansion represents commitment to transform patient care across Western Massachusetts Expansion represents commitment to transform patient care across Western Massachusetts
Markets continued their bull rally today after a small setback yesterday, with all three major markets in the green. Make the most of this market with today's Top Buys from Q.ai's artificial intelligence.
The stimulus packages that many governments have developed in order to rebuild after Covid-19 are often allocating large amounts of financial resources to the health care sector, with a significant focu...
Mainstream cloud vendors backed away from the healthcare space a decade ago, fearful of regulation, but they're now adapting to regulation in their main markets and might want to get back in. The post C...
Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.
Growth investors and dividend collectors alike should consider CERN stock now as the company posts indisputably solid fiscal figures. The post Cerner Is a Strong Value Based on Ultra-Firm Financials app...
3 Medical Info System Stocks to Bank on Despite Decline in COVID-19 Cases
Cerner (CERN) reported earnings 30 days ago. What's next for the stock?
As rumors swirl around a possible acquisition for electronic health record company Cerner, consider picking up CERN stock. The post Cerner Might Be an Acquisition Target Soon appeared first on InvestorP...
PHOENIX & SEATTLE--(BUSINESS WIRE)-- #digitalhealth--Banner Health launches digital health program with Xealth and Babyscripts.
KANSAS CITY, Mo., May 19, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to sto...
NEW YORK--(BUSINESS WIRE)--Kantar Health today announced that Jeremy Brody, Chief Strategy Officer, has been named a 2021 ELITE Winner at the 2021 PM360 Elite Awards.
Cerner's (CERN) first-quarter results benefit from gains in Licensed software, Subscriptions and Managed services units, and expansion in gross margin.
Cerner (CERN) delivered earnings and revenue surprises of 2.70% and -0.90%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Cerner Corp (NASDAQ: CERN) reported a first-quarter FY21 revenue decline of 2% year-on-year to $1.388 billion, missing the analyst consensus of $1.4 billion. It clocked a 2% revenue growth excluding div...
Shares of Cerner (NASDAQ:CERN) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were up 7.04% over the past year to $0.76, which beat the estimate of $0.74.
Increased 2021 Earnings Outlook on Strong Margin Expansion Board Authorizes New $3.75 Billion Share Repurchase Program
Cerner (CERN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cerner's (CERN) first-quarter results are likely to reflect gains from strategic deals.
Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company Ranked #57 Moving Up 230 Spots From Last Year Company Ranked #57 Moving Up 230 Spots From Last Year
Jerome Dodson (Trades, Portfolio)'s Parnassus Fund sold shares of the following stocks during the first quarter, which ended on March 31.
KANSAS CITY, Mo., April 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its first quarter 2021 earnings results before the market opens Wednesday, May 5th....
Some healthcare companies are a good value even with the stock market at all-time highs.
NEW YORK--(BUSINESS WIRE)--The International Gaucher Alliance and Kantar Health launch GARDIAN: Gaucher Registry for Development Innovation and Analysis of Neuronopathic Disease
Which digital healthcare company is a better long-term investment?
Cerner Corporation (NASDAQ: CERN) announced it is acquiring Kantar Health, a Kantar Group division, for $375 million in cash. Kantar Health's life sciences research and consulting solutions will be comb...
Pairing data and research expertise to revolutionize the discovery, development and commercialization of life sciences innovations Pairing data and research expertise to revolutionize the discovery, dev...
KANSAS CITY, Mo., March 26, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to s...
NEW YORK--(BUSINESS WIRE)--New York Life, America's largest mutual life insurer, announces a collaboration with Cerner Corporation, a global health care technology company.
KANSAS CITY, Mo., March 22, 2021 (GLOBE NEWSWIRE) -- It is with tremendous sadness that Cerner Corporation (NASDAQ: CERN) announces that Linda M. Dillman, a long-time and trusted board member, passed aw...
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A media mogul was among the insiders making purchases this week.
Cerner (CERN) reported earnings 30 days ago. What's next for the stock?
The markets have gone into a tailspin again and there are some good deals out there for savvy investors.
Cerner's (CERN) fourth-quarter results benefit from gains in Subscriptions and Managed services units, and expansion in gross margin.
Cerner (CERN) delivered earnings and revenue surprises of 0.00% and 0.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Cerner (NASDAQ:CERN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 4.00% over the past year to $0.78, which were in line with th...
Strong Finish to Year with All Key Metrics Within Company Guidance Ranges
Cerner (NASDAQ:CERN) unveils its next round of earnings this Wednesday, February 10. Get prepared with Benzinga's ultimate preview for Cerner's Q4 earnings.
Cerner's (CERN) fourth-quarter results are likely to reflect gains from strategic deals.
About CERN
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-... [Read more...]
| Industry Health Information Services | IPO Date Dec 5, 1986 |
| CEO Brent Shafer | Employees 26,400 |
| Stock Exchange NASDAQ | Ticker Symbol CERN |
Financial Performance
In 2020, Cerner's revenue was $5.51 billion, a decrease of -3.28% compared to the previous year's $5.69 billion. Earnings were $780.09 million, an increase of 47.34%.
Analyst Forecasts
According to 23 analysts, the average rating for Cerner stock is "Buy." The 12-month stock price forecast is 82.26, which is an increase of 5.07% from the latest price.